- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT04497844
Um estudo de niraparibe em combinação com acetato de abiraterona e prednisona versus acetato de abiraterona e prednisona para o tratamento de participantes com linha germinal deletéria ou reparo de recombinação homóloga somática (HRR) com mutação genética, câncer de próstata metastático sensível à castração (mCSPC) (AMPLITUDE)
Um estudo de fase 3 randomizado, controlado por placebo, duplo-cego de niraparibe em combinação com acetato de abiraterona e prednisona versus acetato de abiraterona e prednisona para o tratamento de participantes com linha germinativa deletéria ou reparo de recombinação homóloga somática (HRR) geneticamente mutante metastático sensível à castração Câncer de Próstata (mCSPC)
The purpose of the study is to determine if the combination of niraparib with Abiraterone Acetate (AA) plus prednisone compared with AA plus prednisone in participants with deleterious germline or somatic Homologous Recombination Repair (HRR) gene-mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC) provides superior efficacy in improving radiographic progression-free survival (rPFS).
Visão geral do estudo
Status
Condições
Tipo de estudo
Inscrição (Real)
Estágio
- Fase 3
Contactos e Locais
Locais de estudo
-
-
-
Braunschweig, Alemanha, 38126
- Städtisches Klinikum Braunschweig gGmbH - Standort Salzdahlumer
-
Cologne, Alemanha, 50937
- Universitaetsklinikum Koelnt
-
Dresden, Alemanha, 01307
- Universitätsklinik Carl Gustav Carus, Med. Klinik u. Poliklinik I
-
Duisburg, Alemanha, 47169
- Urologicum Duisburg
-
Hanover, Alemanha, 30625
- Medizinische Hochschule Hannover
-
München, Alemanha, 81675
- Klinikum rechts der Isar - III. Med. Klinik und Poliklinik
-
Münster, Alemanha, 48149
- Universitaetsklinikum Muenster
-
Nürtingen, Alemanha, 72622
- Studienpraxis Urologie Drs. Feyerabend
-
-
-
-
-
Buenos Aires, Argentina, C1419AHN
- Asociacion de Beneficencia Hospital Sirio Libanes
-
Buenos Aires, Argentina, C1426AGE
- Centro Oncológico Korben
-
Buenos Aires, Argentina, C1061AAS
- CIPREC
-
C.a.b.a., Argentina, C1426BOR
- Hospital Militar Cosme Argerich
-
Caba, Argentina, C1056ABI
- CINME Centro de Investigaciones Metabolicas
-
Ciudad Automoma Buenos Aires, Argentina, C1120AAT
- Centro de Urologia (CDU)
-
Ciudad Autonoma de, Argentina, C1199ABB
- Hospital Italiano de Buenos Aires
-
Ciudad de Buenos Aires, Argentina, C1430EGF
- Clinica Adventista Belgrano
-
Córdoba, Argentina, 5000
- Cemaic Centro Privado de Especialidades Medicas Ambulatorias e Investigacion Clinica
-
Córdoba, Argentina, X5000KPH
- Centro Urologico Profesor Bengio
-
Córdoba, Argentina, X5800
- Instituto Médico de Río Cuarto
-
Córdoba, Argentina, XX5016KEH
- Hospital Privado de Cordoba
-
Mar del Plata, Argentina, B7602CBM
- Hospital Privado de Comunidad
-
Pergamino, Argentina, B2700CPM
- Centro de Investigacion Pergamino SA
-
San Salvador de Jujuy, Argentina, Y4600AFW
- ARS Médica
-
-
-
-
-
Birtinya, Austrália, 4575
- Sunshine Coast University Hospital
-
Darlinghurst, Austrália, 2010
- St Vincent s Hospital Sydney
-
Herston, Austrália, 4029
- Cancer Care Services Clinical Research Unit
-
Hobart, Austrália, 7000
- Royal Hobart Hospital
-
Kurralta Park, Austrália, 5037
- Icon Cancer Centre Kurralta Park
-
Liverpool, Austrália, 2170
- Liverpool Hospital
-
Melbourne, Austrália, 3000
- Peter MacCallum Cancer Centre
-
Murdoch, Austrália, 6150
- Fiona Stanley Hospital
-
North Ryde, Austrália, 2109
- Macquarie University Hospital
-
South Brisbane, Austrália, 4101
- ICON Cancer Care
-
Subiaco, Austrália, 6008
- St John of God Subiaco Hospital
-
-
-
-
-
Babruysk, Bielorrússia, 213825
- Bobruisk Interregional Oncology Dispensary
-
Brest, Bielorrússia, 224027
- Brest Regional Oncology Dispensary
-
Grodno, Bielorrússia, 230017
- Grodno University Hospital
-
Homyel, Bielorrússia, 246012
- Gomel Regional Clinical Oncology Dispensary
-
Lesnoy, Bielorrússia, 223040
- N N Alexandrov National Cancer Centre of Belarus
-
Minsk, Bielorrússia, 220013
- Minsk city Clinical Oncological Dispensary
-
Mogilev, Bielorrússia, 212018
- Mogilev Regional Oncology Dispensary
-
Vitebsk, Bielorrússia, 210603
- Vitebsk Regional Clinical Oncology Dispensary
-
-
-
-
-
Barretos, Brasil, 14784-400
- Fundacao Pio XII
-
Belo Horizonte, Brasil, 30110-022
- Cetus Oncologia
-
Belo Horizonte, Brasil, 30130-090
- PERSONAL Oncologia de Precisao e Personalizada
-
Curitiba, Brasil, 80810 050
- CIONC Centro Integrado de Oncologia de Curitiba
-
Florianópolis, Brasil, 88020 210
- Grupo ELORA Centro de Pesquisa e Ensino em Saude de Santa Catarina
-
Fortaleza, Brasil, 60 810180
- Pronutrir
-
Goiânia, Brasil, 74605-070
- Associacao de Combate ao Cancer em Goias - Hospital de Cancer Araujo Jorge
-
Ipatinga, Brasil, 35162 189
- Fundacao Sao Francisco Xavier
-
Joinville, Brasil, 89201-260
- Instituto Joinvilense de Hematologia e Oncologia Ltda Centro de Hematologia e Oncologia
-
Natal, Brasil, 59075-740
- Liga Norte Riograndense Contra O Cancer
-
Pelotas, Brasil, 96020 080
- UPCO Unidade de Pesquisa Clinica em Oncologia
-
Porto Alegre, Brasil, 90020-090
- Irmandade Santa Casa de Misericordia de Porto Alegre
-
Porto Alegre, Brasil, 90160-093
- Hospital Ernesto Dornelles
-
Recife, Brasil, CEP: 50070
- MultiHemo Servicos Medicos S.A
-
Rio de Janeiro, Brasil, 20551-030
- Universidade do Estado do Rio de Janeiro - UERJ
-
Rio de Janeiro, Brasil, 22250 905
- Oncoclinicas Rio de Janeiro S A
-
Rio de Janeiro, Brasil, 20230-130
- Ministerio da Saude Instituto Nacional do Cancer
-
Rio de Janeiro, Brasil, 22775 001
- Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI)
-
Salvador, Brasil, 40170 110
- Nucleo de Oncologia da Bahia
-
Salvador, Brasil, 41253 190
- Hospital Sao Rafael
-
Santo André, Brasil, 09060 870
- Fundacao do ABC Centro Universitario FMABC
-
Sorocaba, Brasil, 18030-005
- IOS - Instituto de Oncologia de Sorocaba Dr. Gilson Delgado
-
São Paulo, Brasil, 04014-002
- Núcleo de Pesquisa São Camilo
-
São Paulo, Brasil, 01236-030
- Instituto de Ensino e Pesquisa São Lucas
-
São Paulo, Brasil, 01221 020
- Instituto do Cancer Arnaldo Vieira de Carvalho
-
São Paulo, Brasil, 04039-004
- Instituto de Assistencia Medica ao Servidor Publico Estadual IAMSPE
-
São Paulo, Brasil, 01246 000
- Fundacao Faculdade de Medicina - Instituto do Cancer do Estado de Sao Paulo
-
São Paulo, Brasil, 01221-020
- Irmandade Santa Casa de Misericordia de Sao Paulo
-
São Paulo, Brasil, 01421-000
- Hospital Alemao Oswaldo Cruz
-
São Paulo, Brasil, 01323 900
- Real e Benemerita Associacao Portuguesa de Beneficencia
-
Uberlândia, Brasil, 38408-150
- Centro Oncológico do Triângulo
-
-
-
-
-
Burgas, Bulgária, 8001
- MHAT Deva Maria
-
Pleven, Bulgária, 5800
- UMHAT Dr Georgi Stranski EAD 1
-
Plovdiv, Bulgária, 4004
- Complex Oncology Center - Plovdiv EOOD
-
Sofia, Bulgária, 1756
- Specialized Hospital for Active Treatment in Oncology
-
Sofia, Bulgária, 1797
- UMHAT Sofia Med
-
Sofia, Bulgária, 1330
- Multifunctional Hospital for Active Treatment for Women Health Nadezhda
-
Vratsa, Bulgária, 3001
- Comprehensive Cancer Center
-
-
-
-
-
Antwerp, Bélgica, 2020
- ZNA Middelheim
-
Antwerp, Bélgica, 2610
- ZAS Augustinus
-
Charleroi, Bélgica, 6060
- Grand Hopital De Charleroi Site Les Viviers
-
Haine-St-Paul, Bélgica, 7100
- Jolimont
-
Liège, Bélgica, 4000
- CHC MontLegia
-
Namur, Bélgica, 5000
- CHU UCL Namur - Site Sainte Elisabeth
-
Ottignies, Bélgica, 1340
- Clinique St Pierre
-
Roeselare, Bélgica, 8800
- Algemeen Ziekenhuis Delta
-
-
-
-
Alberta
-
Calgary, Alberta, Canadá, T2V 1P9
- Prostate Cancer Centre
-
Edmonton, Alberta, Canadá, T6G 1Z2
- Cross Cancer Institute
-
-
British Columbia
-
Kelowna, British Columbia, Canadá, V1Y 5L3
- British Columbia Cancer Agency(BCCA)-Sindi Ahluwalia Hawkins Centre for the Southern Interior(CSI)
-
Vancouver, British Columbia, Canadá, V5Z 4E6
- British Columbia Cancer Agency BCCA Vancouver Centre
-
Victoria, British Columbia, Canadá, V8R 6V5
- British Columbia Cancer Agency Vancouver Island Centre
-
-
Ontario
-
Hamilton, Ontario, Canadá, L8N 4A6
- McMaster Institute of Urology
-
Kingston, Ontario, Canadá, K7L2V7
- Kingston Health Sciences Centre, Kingston General Health Research Institute
-
Toronto, Ontario, Canadá, M5G2M9
- Princess Margaret Cancer Centre University Health Network
-
Toronto, Ontario, Canadá, M4N 3M5
- Sunnybrook Health Sciences Center
-
-
Quebec
-
Montreal, Quebec, Canadá, H3T 1E2
- McGill University - Jewish General Hospital
-
Montreal, Quebec, Canadá, H2X 0A9
- Centre Hospitalier de l'Universite de Montreal
-
-
-
-
-
Beijing, China, 100142
- Beijing Cancer Hospital
-
Beijing, China, 100730
- Beijing Hospital
-
Beijing, China, 100034
- Peking University First Hospital
-
Beijing, China, 100021
- Cancer Hospital Chinese Academy of Medical Sciences
-
Beijing, China, 100191
- Beijing University Third Hospital
-
Beijing, China, 100050
- Beijing Friendship Hospital Capital Medical University
-
Chengdu, China, 610041
- West China Hospital of Sichuan University
-
Chengdu, China, 610083
- Western Theater General Hospital of the Chinese People's Liberation Army
-
Chengdu, China, 610072
- Sichuan Provincial Peoples Hospital
-
Chongqing, China, 400030
- Chongqing University Cancer Hospital
-
Chongqing, China, 400038
- Southwest Hospital, The Third Military Medical University
-
Guangzhou, China, 510180
- Guangzhou First Municipal People's Hospital
-
Guangzhou, China, 510289
- Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
-
Guangzhou, China, 430030
- Sun Yat Sen University Cancer Center
-
Hangzhou, China, 310014
- Zhejiang Provincial People's Hospital
-
Nanchang, China, 330006
- The First Affiliated Hospital of NanChang University
-
Nanjing, China, 210008
- Nanjing Drum Tower Hospital
-
Nanjing, China, 210000
- Jiangsu Province Cancer Hospital
-
Ningbo, China, 315010
- The First Affiliated Hospital of Ningbo University
-
Shanghai, China, 200032
- Fudan University Shanghai Cancer Center
-
Shanghai, China, 200040
- Huashan Hospital Fudan University
-
Shanghai, China, 200240
- The Fifth People's Hospital of Shanghai, Fudan University
-
Shanghai, China, 200127
- Renji Hospital Affiliated to Medical College of Shanghai Jiaotong University
-
Shanghai, China, 200400
- Huadong Hospital Affiliated to Fudan University
-
Shenyang, China, 110004
- Shengjing Hospital Of China Medical University
-
Suzhou, China, 215006
- The First Affliated Hospital of Soochow University
-
Suzhou, China, 200233
- Second Affiliated Hospital of Soochow University
-
Wenzhou, China, 325000
- The First Affiliated Hospital of Wenzhou Medical University
-
Wuhan, China, 430030
- TongJi Hospital of TongJi Medical College of Huazhong University of Science & Technology
-
Xi'an, China, 710061
- The First Affiliated Hospital of Xian Jiaotong University
-
-
-
-
-
Busan, Coréia do Sul, 49241
- Pusan National University Hospital
-
Daegu, Coréia do Sul, 41404
- Kyungpook National University Chilgok Hospital
-
Daegu, Coréia do Sul, 42601
- Keimyung University Dongsan Hospital
-
Daejeon, Coréia do Sul, 35015
- Chungnam National University Hospital
-
Gwangju, Coréia do Sul, 61469
- Chonnam National University Hospital
-
Gyeonggi-do, Coréia do Sul, 10408
- National Cancer Center
-
Seongnam-si, Coréia do Sul, 13620
- Seoul National University Bundang Hospital
-
Seoul, Coréia do Sul, 03080
- Seoul National University Hospital
-
Seoul, Coréia do Sul, 05505
- Asan Medical Center
-
Seoul, Coréia do Sul, 03722
- Severance Hospital Yonsei University Health System
-
Seoul, Coréia do Sul, 06351
- Samsung Medical Center
-
Seoul, Coréia do Sul, 06591
- The Catholic University of Korea Seoul St Mary s Hospital
-
Seoul, Coréia do Sul, 06273
- Gangnam Severance Hospital, Yonsei University Health System
-
Suwon, Coréia do Sul, 16499
- Ajou University Hospital
-
-
-
-
-
Aalborg, Dinamarca, 9000
- Aalborg University Hospital
-
Copenhagen, Dinamarca, 2100
- Copenhagen University Hospital
-
Herlev, Dinamarca, DK-2730
- Herlev Hospital
-
Næstved, Dinamarca, 4700
- Næstved Hospital
-
Odense, Dinamarca, DK-5000
- Odense Universitetshospital
-
Vejle, Dinamarca, DK-7100
- Vejle Hospital
-
-
-
-
-
A Coruña, Espanha, 15006
- Hosp Univ A Coruna
-
Barcelona, Espanha, 08025
- Hosp. de La Santa Creu I Sant Pau
-
Barcelona, Espanha, 08036
- Hosp Clinic de Barcelona
-
Castellon, Espanha, 12004
- Hosp. Gral. Univ. de Castellon
-
Girona, Espanha, 17007
- Institut Català D'Oncologia Girona
-
Jerez de la Frontera, Espanha, 11407
- Hosp. de Jerez de La Frontera
-
Madrid, Espanha, 28041
- Hosp. Univ. 12 de Octubre
-
Madrid, Espanha, 28034
- Hosp. Univ. Ramon Y Cajal
-
Madrid, Espanha, 28046
- Hosp. Univ. La Paz
-
Madrid, Espanha, 28006
- Hosp. Univ. de La Princesa
-
Madrid, Espanha, 28660
- Hosp. Univ. Hm Monteprincipe
-
Málaga, Espanha, 29010
- Hosp Virgen de La Victoria
-
Sabadell, Espanha, 08208
- Corporacio Sanitari Parc Tauli
-
Santander, Espanha, 39008
- Hosp. Univ. Marques de Valdecilla
-
Seville, Espanha, 41013
- Hosp. Virgen Del Rocio
-
Valencia, Espanha, 46010
- Hosp. Clinico Univ. de Valencia
-
-
-
-
Alabama
-
Homewood, Alabama, Estados Unidos, 35209
- Urology Centers Of Alabama
-
-
Arizona
-
Phoenix, Arizona, Estados Unidos, 85054
- Mayo Clinic Arizona
-
Tucson, Arizona, Estados Unidos, 85741
- Urological Associates of Southern Arizona, P.C.
-
-
California
-
Los Angeles, California, Estados Unidos, 90073
- Greater Los Angeles VA Healthcare System
-
Orange, California, Estados Unidos, 92868
- University of California Irvine Medical Center Chao Family Comprehensive Cancer Center
-
San Bernardino, California, Estados Unidos, 92404
- San Bernardino Urological Associates
-
San Francisco, California, Estados Unidos, 94158
- University of San Francisco California
-
-
Colorado
-
Colorado Springs, Colorado, Estados Unidos, 80907
- Rocky Mountain Cancer Centers
-
Denver, Colorado, Estados Unidos, 80210
- AdventHealth Medical Group Urology of Denver
-
Lakewood, Colorado, Estados Unidos, 80228
- Colorado Clinical Research
-
-
Connecticut
-
Norwich, Connecticut, Estados Unidos, 06360
- Eastern Connecticut Hematology & Oncology Assoc.
-
-
Florida
-
Daytona Beach, Florida, Estados Unidos, 32114
- Advanced Urology Institute
-
Fort Lauderdale, Florida, Estados Unidos, 33308
- Holy Cross Hospital - Michael and Dianne Bienes Comprehensive Cancer Center
-
Jacksonville, Florida, Estados Unidos, 32256
- Cancer Specialists of North Florida
-
Jacksonville, Florida, Estados Unidos, 32209
- University of Florida Health Jacksonville
-
-
Indiana
-
Greenwood, Indiana, Estados Unidos, 46143
- Urology of Indiana
-
Jeffersonville, Indiana, Estados Unidos, 47130
- First Urology
-
-
Louisiana
-
New Orleans, Louisiana, Estados Unidos, 70121
- Ochsner Clinic Foundation
-
-
Maryland
-
Baltimore, Maryland, Estados Unidos, 21201
- Baltimore VA Medical Center
-
Columbia, Maryland, Estados Unidos, 21044
- Maryland Oncology Hematology, PA
-
Towson, Maryland, Estados Unidos, 21204
- Chesapeake Urology Associates
-
-
Michigan
-
Troy, Michigan, Estados Unidos, 48084
- Michigan Institute of Urology
-
-
Missouri
-
Saint Joseph, Missouri, Estados Unidos, 64507
- Mosaic Life Care
-
St Louis, Missouri, Estados Unidos, 63109
- St. Louis VA Medical Center
-
-
Nebraska
-
Omaha, Nebraska, Estados Unidos, 68130
- GU Research Network
-
-
New York
-
Albany, New York, Estados Unidos, 12206
- New York Oncology Hematology
-
New York, New York, Estados Unidos, 10065
- Memorial Sloan Kettering Cancer Center
-
New York, New York, Estados Unidos, 10029
- Mount Sinai
-
New York, New York, Estados Unidos, 10010
- Manhattan VAMC
-
Syracuse, New York, Estados Unidos, 13210
- Associated Medical Professionals
-
The Bronx, New York, Estados Unidos, 10461
- Montefiore Medical Center
-
-
North Carolina
-
Durham, North Carolina, Estados Unidos, 27705
- Durham VAMC
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Estados Unidos, 73104
- Stephenson Cancer Center
-
-
Oregon
-
Portland, Oregon, Estados Unidos, 97239
- VA Portland Health Care System
-
Salem, Oregon, Estados Unidos, 97301
- Oregon Oncology Specialists
-
-
Pennsylvania
-
Lancaster, Pennsylvania, Estados Unidos, 17604
- Keystone Urology Specialists
-
Philadelphia, Pennsylvania, Estados Unidos, 19104
- University of Pennsylvania
-
Philadelphia, Pennsylvania, Estados Unidos, 19104
- Philadelphia VA Medical Center
-
Pittsburgh, Pennsylvania, Estados Unidos, 15232
- University of Pittsburgh Medical Center (UPMC)
-
-
South Carolina
-
Charleston, South Carolina, Estados Unidos, 29401
- Ralph H. Johnson Veterans Affairs Medical Center
-
Seneca, South Carolina, Estados Unidos, 29672
- Prisma Health
-
-
Tennessee
-
Nashville, Tennessee, Estados Unidos, 37209
- Urology Associates
-
-
Texas
-
Austin, Texas, Estados Unidos, 78731
- Texas Oncology-Austin
-
Denton, Texas, Estados Unidos, 76201
- Texas Oncology - Northeast
-
Houston, Texas, Estados Unidos, 77027
- Houston Metro Urology
-
New Braunfels, Texas, Estados Unidos, 78130
- Texas Oncology P A
-
Tyler, Texas, Estados Unidos, 75702
- Texas Oncology - Northeast 1
-
-
Utah
-
Salt Lake City, Utah, Estados Unidos, 84112
- University of Utah Huntsman Cancer Institute
-
-
Virginia
-
Norfolk, Virginia, Estados Unidos, 23502
- Virginia Oncology Associates
-
Richmond, Virginia, Estados Unidos, 23298
- Virginia Commonwealth University - Massey Cancer Center
-
-
Washington
-
Seattle, Washington, Estados Unidos, 98109
- Fred Hutchinson Cancer Research Center
-
Seattle, Washington, Estados Unidos, 98108
- VA Puget Sound Healthcare System
-
Tacoma, Washington, Estados Unidos, 98405
- MultiCare Health System
-
-
-
-
-
Angers, França, 49933
- Institut de Cancerologie de l Ouest ICO
-
Avignon, França, 84918
- Institut Sainte Catherine
-
Besançon, França, 25030
- CHRU De Besancon
-
Bordeaux, França, 33000
- Institut Bergonie
-
Clermont-Ferrand, França, 63011
- Centre Jean Perrin
-
Dijon, França, 21000
- Centre Georges Francois Leclerc
-
Lille, França, 59000
- Centre Oscar Lambret
-
Lyon, França, 69008
- Hopital Prive Jean Mermoz
-
Lyon, França, 69008
- Centre Leon Berard
-
Montpellier, França, 34298
- Institut Regional du Cancer de Montpellier Val d'Aurelle
-
Nancy, França, 54100
- Polyclinique de Gentilly
-
Poitiers, França, 86021
- CHU De Poitiers
-
Quimper, França, 29000
- Centre Hopitalier Inter-Communal De Cornouaille
-
Saint-Mandé, França, 94163
- HIA Begin
-
Saint-Priest-en-Jarez, França, 42271
- Institut de Cancérologie de Loire
-
Strasbourg, França, 67000
- Clinique Sainte Anne
-
Suresnes, França, 32151
- Hopital Foch
-
Tours, França, 37044
- CHRU de Tours
-
-
-
-
-
Delft, Holanda, 2625 AD
- Reinier de Graaf Gasthuis
-
Hilversum, Holanda, 1213XZ
- Tergooiziekenhuizen
-
Nijmegen, Holanda, 6532 SZ
- Canisius-Wilhelminaziekenhuis
-
Tilburg, Holanda, 5022 GC
- Elisabeth-TweeSteden Ziekenhuis
-
-
-
-
-
Budapest, Hungria, 1204
- Jahn Ferenc Del-pesti Korhaz es Rendelointezet
-
Debrecen, Hungria, 4032
- Debreceni Egyetem
-
Gyula, Hungria, 5700
- Bekes Megyei Kozponti Korhaz Pandy Kalman Tagkorhaz
-
Győr, Hungria, 9024
- Petz Aladar Megyei Oktato Korhaz
-
Miskolc, Hungria, 3526
- Borsod Abauj Zemplen Varmegyei Kozponti Korhaz es Egyetemi Oktato Korhaz
-
Szeged, Hungria, 6720
- Szegedi Tudomanyegyetem
-
Tatabánya, Hungria, 2800
- Szent Borbala Hospital Tatabanya
-
-
-
-
-
Afula, Israel, 1834111
- Haemek Medical Center - Afula
-
Beersheba, Israel, 85101
- Soroka Hospital
-
Haifa, Israel, 31096
- Rambam Medical Center
-
Jerusalem, Israel, 91200
- Hadassah Hospital
-
Petach Tikvah, Israel, 49100
- Rabin Medical Center, Beilinson Hospital
-
Ramat Gan, Israel, 52621
- Sheba Medical Center Tel Hashomer
-
Tel Aviv, Israel, 64239
- Tel Aviv Sourasky Medical Center
-
-
-
-
-
Arezzo, Itália, 52100
- Ospedale S. Donato - Asl 8 Arezzo
-
Candiolo, Itália, 10060
- Divisione di Oncologia - Istituto per la ricerca e cura del cancro
-
Cremona, Itália, 26100
- Istituti Ospitalieri di Cremona, AO di Cremona
-
Lecce, Itália, 73100
- Azienda Ospedaliera ''Vito Fazzi''
-
Meldola, Itália, 47014
- Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
-
Milan, Itália, 20132
- Ospedale San Raffaele
-
Milan, Itália, 20133
- Fondazione IRCCS Istituto Nazionale dei Tumori
-
Milan, Itália, 20141
- European Institute of Oncology
-
Naples, Itália, 80138
- Fondazione G Pascale Istituto Nazionale Tumori IRCCS
-
Orbassano, Itália, 10043
- Aou San Luigi Gonzaga
-
Padova, Itália, 35128
- Istituto Oncologico Veneto Iov Irccs Padova
-
Pisa, Itália, 56126
- Azienda Ospedaliero Universitaria Pisana
-
Pozzuoli, Itália, 80078
- ASL Napoli 2 Nord-SM delle Grazie Hospital
-
San Giovanni Rotondo, Itália, 71013
- Casa Sollievo Della Sofferenza IRCCS
-
Trento, Itália
- Ospedale S. Chiara
-
Vicenza, Itália, 36100
- Ospedale San Bortolo
-
-
-
-
-
George Town, Malásia, 10990
- Hospital Pulau Pinang
-
Johor Bahru, Malásia, 81100
- Hospital Sultan Ismail
-
Kuala Lumpur, Malásia, 50586
- Hospital Kuala Lumpur
-
Kuala Lumpur, Malásia, 59100
- University Malaya Medical Centre
-
Kuching, Malásia, 93586
- Sarawak General Hospital
-
Putrajaya, Malásia, 62250
- Institut Kanser Negara Clinical Research Center
-
-
-
-
-
Durango, México, 34000
- Consultorio de Especialidad en Urologia Privado
-
León, México, 37000
- Consultorio Privado
-
Mexico City, México, 3720
- Centro de Investigacion Clínica Gramel S.C.1
-
Monterrey, México, 64710
- i Can Oncology Center
-
Monterrey, México, 64710
- Avix Investigacion Clinica S C
-
Naucalpan, México, 53100
- Oncologia Integral Satelite
-
Oaxaca City, México, 68020
- Centro de Investigacion Clinica de Oaxaca
-
Zapopan, México, 45040
- Consultorio Privado 1
-
-
-
-
-
Auckland, Nova Zelândia, 1023
- Auckland City Hospital
-
Christchurch, Nova Zelândia, 8013
- Canterbury Urology Research Trust
-
Dunedin Central, Nova Zelândia, 9016
- Dunedin Hospital
-
Tauranga, Nova Zelândia, 3112
- Tauranga Hospital
-
-
-
-
-
Bydgoszcz, Polônia, 85 048
- IN VIVO Sp. z o.o
-
Bydgoszcz, Polônia, 85 094
- Szpital Uniwersytecki NR 1 IM Dr Antoniego Jurasza
-
Bydgoszcz, Polônia, 85 796
- Centrum Onkologii im Prof F Lukaszczyka
-
Gdynia, Polônia, 81 519
- Szpitale Pomorskie Sp z o o
-
Konin, Polônia, 62-500
- Przychodnia Lekarska KOMED Roman Karaszewski
-
Krakow, Polônia, 30 539
- Klinika MedTrials
-
Lodz, Polônia, 93-509
- Wojewodzki Szpital Specjalistyczny im. M. Kopernika w Lodzi
-
Lublin, Polônia, 20-223
- Medisport
-
Siedlce, Polônia, 08-110
- Urologica Praktyka Lekarska Adam Marcheluk
-
Warsaw, Polônia, 04 073
- Szpital Grochowski Im Dr Med Rafala Masztaka Sp Z O O
-
Wroclaw, Polônia, 53-329
- Specjalistyczna przychodnia lekarska POLIMED
-
-
-
-
-
Hato Rey, Porto Rico, 00917
- Puerto Rico Medical Research Center
-
-
-
-
-
Almada, Portugal, 2805-607
- Uls Almada Seixal - Hosp. Garcia de Orta
-
Coimbra, Portugal, 3000075
- Instituto Português de Oncologia Francisco Gentil - Centro Regional de Oncologia de Coimbra, S.A.
-
Lisbon, Portugal, 1400-038
- Fund. Champalimaud
-
Lisbon, Portugal, 1649 035
- Uls Santa Maria - Hosp. Santa Maria
-
-
-
-
-
Bangor, Reino Unido, LL57 2PW
- Ysbyty Gwynedd
-
Belfast, Reino Unido, BT9 7AB
- Belfast City Hospital
-
Brighton, Reino Unido, BN2 5BE
- Brighton and Sussex University Hospitals NHS Trust
-
Bristol, Reino Unido, BS2 8ED
- Bristol Haematology and Oncology Centre
-
Great Maze Pond, Reino Unido, SE1 9RT
- Guy's Hospital
-
Grimsby, Reino Unido, DN33 2BA
- Prince Of Wales Hospital
-
Hillingdon, Reino Unido, HA6 2RN
- Marie Curie Research Wing - Mount Vernon Hospital
-
Inverness, Reino Unido, IV2 3UJ
- Raigmore Hospital
-
London, Reino Unido, NW1 2PG
- University College London Hospitals NHSFT
-
Oxford, Reino Unido, OX3 7LE
- Churchill Hospital
-
Preston, Reino Unido, PR2 9HT
- Royal Preston Hospital
-
Sutton, Reino Unido, SM2 5PT
- Royal Marsden Hospital
-
Truro, Reino Unido, TR1 3LJ
- Royal Cornwall Hospitals NHS Trust - Royal Cornwall Hospital
-
-
-
-
-
Barnaul, Rússia, 656045
- Altai Regional Oncology Dispensary
-
Chelyabinsk, Rússia, 454087
- Chelyabinsk Regional Clinical Center Of Oncology And Nuclear Medicine
-
Ivanovo, Rússia, 153040
- Ivanovo Regional Oncology Dispensary
-
Moscow, Rússia, 125130
- Moscow City Clinical Hospital # 62
-
Moscow, Rússia, 125284
- Hertzen Oncology Research Institute
-
Nizhny Novgorod, Rússia, 603001
- Privolzhsky District Medical Centre
-
Omsk, Rússia, 644013
- Clinical Oncology Dispensary
-
Pyatigorsk, Rússia, 357500
- LLC Novaya Clinica
-
Pyatigorsk, Rússia, 357502
- Pyatigorsk Interdistrict Oncology Dispensary
-
Saint Petersburg, Rússia, 196603
- Private Medical Institution Euromedservice
-
Saint Petersburg, Rússia, 191104
- Leningrad Regional Oncology Dispensary
-
Saransk, Rússia, 430032
- Republican Oncology Dispensary
-
Tomsk, Rússia, 634050
- Tomsk Cancer Research Institute
-
Tyumen, Rússia, 625041
- Multifunctional clinical medical center 'Medical city'
-
Ufa, Rússia, 450083
- Bashkir State Medical University
-
-
-
-
-
Gothenburg, Suécia, 413 45
- Salgrenska University hospital
-
Malmö, Suécia, 205 02
- Urologiska Mottagningen
-
Stockholm, Suécia, 17164
- Karolinska Universitetssjukhuset Solna
-
Stockholm, Suécia, 11883
- Sodersjukhuset
-
-
-
-
-
Bangkok, Tailândia, 10330
- King Chulalongkorn Memorial Hospital
-
Bangkok, Tailândia, 10700
- Siriraj Hospital
-
Bangkok, Tailândia, 10400
- Ramathibodi Hospital
-
-
-
-
-
Kaohsiung City, Taiwan, 83301
- Kaohsiung Chang Gung Memorial Hospital
-
Kaohsiung City, Taiwan, 807
- Kaohsiung Medical University Chung Ho Memorial Hospital
-
Taichung, Taiwan, 40447
- China Medical University Hospital
-
Taichung, Taiwan, 40705
- Taichung Veterans General Hospital
-
Taichung, Taiwan, 435
- Tungs' Taichung MetroHarbor Hospital
-
Taipei, Taiwan, 10002
- National Taiwan University Hospital
-
Taipei, Taiwan, 11217
- Taipei Veterans General Hospital
-
Taoyuan, Taiwan, 333
- Chang-Gung Memorial Hospital, LinKou Branch
-
-
-
-
-
Brno, Tcheca, 656 91
- Fakultni nemocnice u sv. Anny v Brne
-
Hradec Králové, Tcheca, 500 05
- FN Hradec Kralove, Urologicka klinika
-
Liberec, Tcheca, 460 63
- Krajská nemocnice Liberec
-
Olomouc, Tcheca, 77900
- Uromedical Center s.r.o.
-
Prague, Tcheca, 128 00
- Urologicka klinika 1 LF UK a VFN
-
-
-
-
-
Adana, Turquia (Türkiye), 01250
- Adana Baskent Yuregir Hospital
-
Ankara, Turquia (Türkiye), 06520
- Memorial Ankara Hastanesi
-
Ankara, Turquia (Türkiye), 06800
- Ankara Bilkent Sehir Hastanesi
-
Ankara, Turquia (Türkiye), 06590
- Ankara University Medical Faculty
-
Ankara, Turquia (Türkiye), 06200
- Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi
-
Ankara, Turquia (Türkiye), 06560
- Gazi Hastanesi
-
Bursa, Turquia (Türkiye), 16310
- Bursa Yuksek lhtisas EAH Medikal Onkoloji Klinigi
-
Edirne, Turquia (Türkiye), 22030
- Trakya University Medical Faculty
-
Istanbul, Turquia (Türkiye), 34147
- Bakirkoy Training and Research Hospital
-
Istanbul, Turquia (Türkiye), 34000
- Istanbul University Istanbul Medical Faculty
-
Istanbul, Turquia (Türkiye), 34098
- Istanbul Universitesi Cerrahpasa Tip Fakultesi Ic Hastaliklari Anabilim Dali Medikal Onkoloji Bd
-
Istanbul, Turquia (Türkiye), 34722
- T C Saglik Bakanlıgi Goztepe Prof Dr Suleyman Yalcın Sehir Hastanesi
-
Izmir, Turquia (Türkiye), 35530
- Izmir Medical Point Hospital
-
Izmir, Turquia (Türkiye), 35340
- Dokuz Eylul Universitesi Arastirma ve Uygulama Hastanesi
-
Sakarya, Turquia (Türkiye), 54050
- Sakarya Üniversitesi Tıp Fakültesi Hastanesi
-
Samsun, Turquia (Türkiye), 55200
- Medical Park Samsun Hastanesi
-
-
-
-
-
Cherkasy, Ucrânia, 18009
- CNE Clinical Center of Oncology Hematology Transplantology and Palliative Care of the Cherkasy RC
-
Chernivtsi, Ucrânia, 58013
- Municipal Non-profit enterprise 'Bukovinian clinical oncology center'
-
Dnipro, Ucrânia, 49102
- Dnipropetrovsk State Medical Academy, Dnipropetrovsk City Multifield Clinical Hospital # 4
-
Dnipro, Ucrânia, 49100
- Municipal Institution 'Clinical Oncology Dispensary' Under Dnipropetrovsk Regional Council
-
Dnipro, Ucrânia, 49005
- Ce 'Dnipropetrovsk Regional Clinical Hospital N.A. Mechnikov' of Dnipropetrovsk Rc
-
Ivano-Frankivsk, Ucrânia, 76008
- Ivano-Frankivsk Regional Clinical Hospital
-
Kamyanske, Ucrânia, 51900
- Communal Institution 'City hospital №7 of Kamianske' of Dnepropetrov'sk Regional Council
-
Khakhiv, Ucrânia, 61070
- Municipal non-profit enterprise 'Regional Center of Oncology'
-
Kharkiv, Ucrânia, 61037
- Regional Medical Clinical Center for Urology and Nephrology named after V.I. Shapoval
-
Kherson, Ucrânia, 73035
- Kherson Regional Oncological Dispensary
-
Kyiv, Ucrânia, 04107
- Kyiv Regional Oncological Dispensary
-
Kyiv, Ucrânia, 03115
- State Institution Institute of Urology NAMS of Ukraine based on Kyiv City Clinical Oncology Center
-
Kyiv, Ucrânia, 03022
- State Nonprofit Enterprise National Cancer Institute
-
Lviv, Ucrânia, 79010
- Communal Noncommercial Enterprise of Lviv Regional Council 'Lviv Regional Clinical Hospital'
-
Vinnitsa, Ucrânia, 21029
- Podilskiy Regional Center of Oncology
-
Zhytomyr, Ucrânia, 10002
- Municipal non-profit enterprise Zhytomyr Regional Oncology Dispensary of Zhytomyr Regional Council
-
-
-
-
-
Cape Town, África do Sul, 7700
- CancerCare Rondebosch
-
Pretoria, África do Sul, 0001
- Steve Biko Academic Hospital
-
Vosloorus, África do Sul, 1475
- East Rand Urology Research Unit
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion criteria:
- Pathological diagnosis of prostate adenocarcinoma
- Must have appropriate deleterious homologous recombination repair (HRR) gene alteration
- Metastatic disease as documented by conventional imaging with computed tomography (CT) or magnetic resonance imaging (MRI) (for soft tissue lesions) or 99mTc bone scan (for bone lesions). Participants with a single bone lesion on Technetium-99m (99mTc) bone scan with no other non-nodal metastatic disease must have confirmation of bone metastasis by CT or MRI. Participants with lymph node-only disease are not eligible
- Androgen deprivation therapy (either medical or surgical castration) must have been started >=14 days prior to randomization and participants be willing to continue androgen deprivation therapy (ADT) through the treatment phase
- Other allowed prior therapy for metastatic castration-sensitive prostate cancer (mCSPC): (a) maximum of 1 course of radiation and 1 surgical intervention for symptomatic control of prostate cancer (example, uncontrolled pain, impending spinal cord compression or obstructive symptoms). Participants with radiation or surgical interventions to all known sites of metastatic disease will be excluded from trial participation. Radiation must be completed prior to randomization (b) Up to a maximum of 6 months of ADT prior to randomization; (c) Up to a maximum of 45 days of abiraterone acetate + prednisone (AA-P) prior to randomization (d) Up to a maximum of 2 weeks of ketoconazole for prostate cancer prior to randomization
Exclusion criteria:
- Prior treatment with a poly (adenosine diphosphate-ribose) polymerase inhibitor (PARP inhibitor)
- History of adrenal dysfunction
- Long-term use of systemically administered corticosteroids (greater than [>] 5 milligrams [mg] of prednisone or the equivalent) during the study is not allowed. Short-term use (<=4 weeks, including taper) and locally administered steroids (for example, inhaled, topical, ophthalmic, and intra-articular) are allowed, if clinically indicated
- History or current diagnosis of myelodysplastic syndrome (MDS)/ acute myeloid leukemia (AML)
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Triplo
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Niraparib with Abiraterone Acetate plus Prednisone (AAP)
Participants will receive the following in each 28-day treatment cycle: niraparib 200 milligrams (mg) + abiraterone acetate (AA) 1000 mg fixed dose combination (FDC) along with placebo for AA and prednisone 5 mg once daily. |
Participants will receive a FDC of Niraparib 200 mg + AA 1000 mg once daily. Participants will receive prednisone 5 mg once daily. Participants will receive matching placebo for AA once daily. |
|
Comparador Ativo: Placebo for Niraparib + AA FDC plus AA and prednisone (AAP)
Participants will receive the following in each 28-day treatment cycle: matching placebo for Niraparib+AA FDC along with AA 1000 mg and prednisone 5 mg once daily. |
Participants will receive prednisone 5 mg once daily. Participants will receive AA 1000 mg once daily. Participants will receive matching placebo for Niraparib +AA FDC once daily. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Breast Cancer Gene (BRCA) Subgroup: Radiographic Progression-free Survival (rPFS) Assessed by Investigator
Prazo: From date of randomization (Day -3 to Day 1) up to approximately 49 months
|
rPFS: time interval from date of randomization to first date of radiographic progression as assessed by investigator or death due to any cause, whichever occurred first. rPFS was determined by: (1) progression of soft tissue lesions measured by computerized tomography (CT) or magnetic resonance imaging (MRI) per response evaluation criteria in solid tumors (RECIST) 1.1; (2) progression of bone lesions observed by bone scan per prostate cancer working group 3 (PCWG3) criteria: bone progression was confirmed by subsequent scan greater than or equal to (>=) 6 weeks later. Week 8 scan was baseline to which all subsequent scans were compared to determine progression. A confirmatory scan with >=2 new lesions indicated progression; A confirmatory scan not showing >=2 new lesions means no progression. If Week 8 scan shows <2 new bone lesions compared to baseline, first scan with >=2 new lesions compared to Week 8 scan indicated progression, when confirmed by a subsequent scan >=6 weeks later. |
From date of randomization (Day -3 to Day 1) up to approximately 49 months
|
|
HRR Effector Subgroup: Radiographic Progression-free Survival (rPFS) Assessed by Investigator
Prazo: From date of randomization (Day -3 to Day 1) up to approximately 49 months
|
rPFS: time interval from date of randomization to first date of radiographic progression as assessed by investigator or death due to any cause, whichever occurred first. rPFS was determined by: (1) progression of soft tissue lesions measured by CT or MRI per RECIST 1.1; (2) progression of bone lesions observed by bone scan per PCWG3 criteria: bone progression was confirmed by subsequent scan >= 6 weeks later. Week 8 scan was baseline to which all subsequent scans were compared to determine progression. A confirmatory scan with >=2 new lesions indicated progression; A confirmatory scan not showing >=2 new lesions means no progression. If Week 8 scan shows <2 new bone lesions compared to baseline, first scan with >=2 new lesions compared to Week 8 scan indicated progression, when confirmed by a subsequent scan >=6 weeks later. |
From date of randomization (Day -3 to Day 1) up to approximately 49 months
|
|
All HRR: Radiographic Progression-free Survival (rPFS) Assessed by Investigator
Prazo: From date of randomization (Day -3 to Day 1) up to approximately 49 months
|
rPFS: time interval from date of randomization to first date of radiographic progression as assessed by investigator or death due to any cause, whichever occurred first. rPFS was determined by: (1) progression of soft tissue lesions measured by CT or MRI per RECIST 1.1; (2) progression of bone lesions observed by bone scan per PCWG3 criteria: bone progression was confirmed by subsequent scan >= 6 weeks later. Week 8 scan was baseline to which all subsequent scans were compared to determine progression. A confirmatory scan with >=2 new lesions indicated progression; A confirmatory scan not showing >=2 new lesions means no progression. If Week 8 scan shows <2 new bone lesions compared to baseline, first scan with >=2 new lesions compared to Week 8 scan indicated progression, when confirmed by a subsequent scan >=6 weeks later. |
From date of randomization (Day -3 to Day 1) up to approximately 49 months
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Sobrevivência Global (OS)
Prazo: Desde a data de randomização (Dia -3 a Dia 1) até 83 meses
|
Desde a data de randomização (Dia -3 a Dia 1) até 83 meses
|
|
|
Tempo até Terapia Subsequente
Prazo: Desde a data de randomização (Dia -3 a Dia 1) até 83 meses
|
Desde a data de randomização (Dia -3 a Dia 1) até 83 meses
|
|
|
Número de Participantes com Eventos Adversos Graves Emergentes do Tratamento
Prazo: Desde o Dia 1 do Ciclo 1 até 83 meses
|
Desde o Dia 1 do Ciclo 1 até 83 meses
|
|
|
Número de Participantes com Eventos Adversos Emergentes do Tratamento por Gravidade
Prazo: Desde o Ciclo 1, Dia 1 até 83 meses
|
Desde o Ciclo 1, Dia 1 até 83 meses
|
|
|
BRCA Subgroup: Time to Symptomatic Progression
Prazo: From date of randomization (Day -3 to Day 1) up to approximately 49 months
|
Time to symptomatic progression was defined as time from the date of randomization to the date of any of the following (whichever occurred first): (a) the use of external beam radiation therapy for skeletal or pelvic symptoms, (b) the need for tumor-related orthopedic surgical intervention, (c) other cancer-related procedures (example: nephrostomy insertion, bladder catheter insertion, external beam radiation therapy, or surgery for tumor symptoms), (d) cancer-related morbid events (that is, fracture [symptomatic and/or pathologic], cord compression, urinary obstructive events), (e) initiation of a new systemic anti-cancer therapy because of cancer symptoms. |
From date of randomization (Day -3 to Day 1) up to approximately 49 months
|
|
HRR Effector Subgroup: Time to Symptomatic Progression
Prazo: From date of randomization (Day -3 to Day 1) up to approximately 49 months
|
Time to symptomatic progression was defined as time from the date of randomization to the date of any of the following (whichever occurred first): (a) the use of external beam radiation therapy for skeletal or pelvic symptoms, (b) the need for tumor-related orthopedic surgical intervention, (c) other cancer-related procedures (example: nephrostomy insertion, bladder catheter insertion, external beam radiation therapy, or surgery for tumor symptoms), (d) cancer-related morbid events (that is, fracture [symptomatic and/or pathologic], cord compression, urinary obstructive events), (e) initiation of a new systemic anti-cancer therapy because of cancer symptoms. |
From date of randomization (Day -3 to Day 1) up to approximately 49 months
|
|
All HRR: Time to Symptomatic Progression
Prazo: From date of randomization (Day -3 to Day 1) up to approximately 49 months
|
Time to symptomatic progression was defined as time from the date of randomization to the date of any of the following (whichever occurred first): (a) the use of external beam radiation therapy for skeletal or pelvic symptoms, (b) the need for tumor-related orthopedic surgical intervention, (c) other cancer-related procedures (example: nephrostomy insertion, bladder catheter insertion, external beam radiation therapy, or surgery for tumor symptoms), (d) cancer-related morbid events (that is, fracture [symptomatic and/or pathologic], cord compression, urinary obstructive events), (e) initiation of a new systemic anti-cancer therapy because of cancer symptoms. |
From date of randomization (Day -3 to Day 1) up to approximately 49 months
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Diretor de estudo: Janssen Research & Development, LLC Clinical Trial, Janssen Research & Development, LLC
Publicações e links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
- Doenças urogenitais
- Doenças Genitais
- Neoplasias Genitais Masculinas
- Neoplasias urogenitais
- Neoplasias por local
- Neoplasias
- Doenças Genitais, Masculino
- Doenças prostáticas
- Doenças Urogenitais Masculinas
- Neoplasias prostáticas
- Compostos policíclicos
- Pregada
- Pregnas
- Esteróides
- Compostos de anel fundido
- PregadaDiols
- Androstenes
- Androstanos
- Acetato de Abiraterona
- Prednisona
Outros números de identificação do estudo
- CR108852
- 2020-002209-25 (Número EudraCT)
- 67652000PCR3002 (Outro identificador: Janssen Research & Development, LLC)
- 2023-506365-64-00 (Identificador de registro: EUCT number)
- 2023 (Concessão/Contrato do NIH dos EUA)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
The data sharing policy of Johnson & Johnson Innovative Medicine is available at innovativemedicine.jnj.com/our-innovation/clinical-trials/transparency. As noted on this site, requests for access to the study data can be submitted through Yale Open Data Access (YODA) Project site at yoda.yale.edu
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .